Fresenius Kabi Oncology Ltd. | FKONCO | NSE - Pharmaceuticals


INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.

 Chart
2012
2013
Cash and cash equiva...
Cash and cash equivalent
1365
Short-term investment
Short-term investments
00
Accounts receivables
Accounts receivables
2,0171,851
Inventories
Inventories
1,8862,451
Deferred income taxes
Deferred income taxes
00
Other current assets
Other current assets
1,248795
Total current assets
Total current assets
5,287
5,102
 
   
Gross property plant...
Gross property plant and equipment
2,9953,472
Accumulated Depriciat...
Accumulated Depriciation and amortization
00
Net property, plant and Eq...
Net property, plant and equipment
2,9953,472
Work in Progress
Work in Progress - Some Companies include it in PPE
1,3381,586
Miscellaneous Investment
Miscellaneous Investments
0.30.3
Deferred income taxes
Deferred income taxes
00
Intangible assets
Intangible assets
9889
Goodwill
Goodwill
00
Other long-term assets
Other long-term assets
383138
Total non-current assets
Total non-current assets
4,815
5,286
Total assets
Total assets
10,101
10,388
 
   
Short-term debt
Short-term debt
521449
Accounts Payable...
Accounts Payable and accrued expenses
1,394914
Provisions
Provisions
771717
Taxes Payable
Taxes Payable
00
Deferred Revenues
Deferred Revenues
00
Capital Leases
Capital Leases
00
Other current liabilities
Other current liabilities
62305
Total current liabilities
Total current liabilities
2,748
2,385
 
   
Long-term debt
Long-term loans and Debentures
952952
Investments Liabilities
Investments Liabilities
00
Deferred tax liabilities
Deferred tax liabilities
147244
Provisions
Provisions
32975
Capital Leases
Capital Leases
00
Other longterm liabilities
Other longterm liabilities
00
Total non-current liabilities
Total non-current liabilities
1,428
1,271
Total liabilities
Total liabilities
4,175
3,656
 
   
Share Capital
Share Capital
158158
Share premium
Share premium
7680
Retained earnings
Retained earnings
5,0006,574
Accumulated other equity
Accumulated other equity
00
Preferred Stock
Preferred Stock
00
Minority Interest
Minority Interest
00
Total Equity
Total Equity
5,926
6,732
Total Liabilities and Equity
Total Liabilities and Equity
10,101
10,388
Cash per Share
Cash per Share
UpgradeUpgrade
Cash, Current Inv Per share
Cash & Current Investment per share
UpgradeUpgrade